Argent Biopharma Ltd (RGT) — Cash Flow Quality Index
Argent Biopharma Ltd (RGT) has a Cash Flow Quality Index of -4.11x as of September 2018. Operating cash flow of AU$-1.34 Million is below net income of AU$326.24K, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Argent Biopharma Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Argent Biopharma Ltd Cash Flow Quality Index (2006–2011)
Historical Cash Flow Quality Index for Argent Biopharma Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see RGT operating cash flow.
Annual Cash Flow Quality Index for Argent Biopharma Ltd (2006–2011)
Year-by-year earnings quality comparison for Argent Biopharma Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2011 | -0.18x | AU$-338.82K | AU$1.94 Million | ▼ -180.3% |
| 2006 | 0.22x | AU$41.00K | AU$188.00K | — |